Showing results (11-20 of 270) with videos related to
Sort By:
Pageof 27
Frontiers in Molecular Biosciences|July 22, 2021
Targeting the Host Response: Can We Manipulate Extracellular Matrix Metalloproteinase Activity to Improve Influenza Virus Infection Outcomes?Jess Pedrina, John StambasJournal of Virology|April 29, 2005
The immune response to human metapneumovirus is associated with aberrant immunity and impaired virus clearance in BALB/c miceRene Alvarez, Ralph A TrippJournal of Virology|September 27, 2008
RNA interference inhibits respiratory syncytial virus replication and disease pathogenesis without inhibiting priming of the memory immune responseWenliang Zhang, Ralph A TrippViruses|November 25, 2023
Screening Drugs for Broad-Spectrum, Host-Directed Antiviral Activity: Lessons from the Development of Probenecid for COVID-19Ralph A Tripp, David E MartinViruses|December 28, 2021
Immunopathology of RSV: An Updated ReviewHarrison C Bergeron, Ralph A TrippVaccines|September 11, 2019
Original Antigenic Sin and Respiratory Syncytial Virus VaccinesRalph A Tripp, Ultan F PowerViruses|March 26, 2022
Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) ReplicationRalph A Tripp, David E MartinViruses|January 25, 2018
Verdinexor Targeting of CRM1 is a Promising Therapeutic Approach against RSV and Influenza VirusesJennifer A Pickens, Ralph A TrippCurrent Topics in Microbiology and Immunology|July 11, 2014
Antiviral effects of inhibiting host gene expressionRalph A Tripp, S Mark TompkinsVaccines|December 6, 2016
Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial VirusPatricia A Jorquera, Ralph A TrippPageof 27